Navigation Links
Mussels -- material artists with grip
Date:3/4/2010

We may like to eat mussels steamed in white wine, but we also like to find mussels at the beach. Mostly they are burrowed into the ground or tethered to rocks. But if you look closer you will find a mollusc which has adapted to life and nutrition in a special and fascinating way. Mussels thrive in rocky seashore habitats, in spite of the enormous physical demands present there. This is in no small part due to the evolution of the byssus, which mussels employ to tether themselves to accessible surfaces.

The individual byssal threads that compose the byssus are stiff, but stretchy and are fashioned by the mussel in a process resembling injection molding. Byssal threads are depended upon for dissipating the energy of crashing waves and also for resisting abrasive damage from water-borne debris. To this end, threads are sheathed with a thin and knobby outer cuticle; a biological polymer, which exhibits epoxy-like hardness, while straining up to 100% without cracking.

Incredible hardness and extensibility

Matthew Harrington, a researcher who worked on the project and Humboldt fellow at the Max Planck Institute for Colloids and Interfaces explains the motivation for studying the byssus cuticle: "Protective coatings are important for prolonging the lifetime of materials and devices. However, considering that hardness and extensibility are seldom coupled in engineered polymers or composites, understanding how one protects a flexible substrate becomes quite important." Byssal cuticles have a knobby appearance due to inclusions of submicron-sized granular structures in an apparently continuous matrix. Submicron-sized tears that form in the matrix during stretching of the cuticle are believed to hinder the formation of larger cracks that could lead to material failure.

Central to understanding the peculiar mechanical behaviour of the cuticle are the high concentration of iron ions in the cuticle and the presence of an uncommon
'/>"/>

Contact: Matthew Harrington
Matt.Harrington@mpikg.mpg.de
49-331-567-9429
Max-Planck-Gesellschaft
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Zebra mussels hang on while quagga mussels take over
2. The Prestige oil spill caused changes in the cell structure of mussels
3. Queens University Belfast works to save Strangford horse mussels
4. Mussels to determine how much contamination is in the ports
5. An electrifying discovery: New material to harvest electricity from body movements
6. New material mimics bone to create better biomedical implants
7. Bioengineered materials promote the growth of functional vasculature, new study shows
8. Supportive materials will help regenerate heart tissue
9. Tough yet stiff deer antler is materials scientists dream
10. NIEHS awards Recovery Act funds to focus more research on health and safety of nanomaterials
11. New beryllium reference material for occupational safety monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/18/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... the risk of acquiring HIV in young African men, according ... professor of epidemiology Robert Bailey. , The study is published ... , Researchers conducted a clinical trial enrolling 2,784 HIV negative, ... Kenya, where an estimated 26 percent of uncircumcised men are ...
... Some day, heart attack survivors might have a patch of ... died during their attack. Children born with defective heart valves ... than being replaced every few years. And people with clogged ... of a factory-made one. , These possibilities are all within ...
... about bird flu, involving the use of a mathematical ... might be the best way to deal with an ... triggered a worldwide human epidemic yet because it rarely ... it would take 6-8 months to develop a vaccine ...
Cached Biology News:Circumcision: A proven strategy to prevent HIV 2Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4
(Date:6/2/2015)... 2, 2015   Hospira, Inc. (NYSE: ... that its partner, Celltrion – a global biopharmaceutical company – ... Surveillance Agency in Brazil – ... for use in Brazil . The ... and sells biosimilar infliximab in 26 European countries and ...
(Date:6/2/2015)... June 02, 2015 “Stem Cell Therapy to ... mainstream, and it is used often as an adjunct to ... practitioners are not yet aware or comfortable enough with the ... is most often reserved for the last resort cases - ... can barely lift a paw to get around. It is ...
(Date:6/2/2015)... June 2, 2015   Intrexon Corporation ... biology, announced today the appointment of Olivier ... Consumer Sector.  Mr. Jarry will lead the expansion ... and applications for consumer markets.  ... of experience in leading global life sciences and ...
(Date:6/2/2015)... 2, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that Dr. Pamela Pavco , ... the 23 rd World Congress of ... include in-depth presentations by world-class clinicians and/or ...
Breaking Biology Technology:ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3Intrexon Announces New Sector Leader 2Intrexon Announces New Sector Leader 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... June 18 HemoCue(R) AB, a,global point-of-care diagnostic ... Incorporated (NYSE: DGX ), today announced,that its ... point-of-care,test for screening for, diagnosing and monitoring microalbuminuria ... Food and Drug Administration (FDA). With,the FDA CLIA ...
... ARUP Laboratories, a national,clinical and anatomic pathology reference ... development, announced today that it has,entered into a ... nationwide network affiliation and a principal provider of,business ... effective June 17, 2008, offers special pricing to ...
... 18 Medarex, Inc.,(Nasdaq: MEDX ) announced today ... Annual Healthcare Conference at 11:15 a.m. Eastern Time on,Wednesday, ... and will be,available in the Investor Relations section of ... of the presentation will be available,following the event., ...
Cached Biology Technology:HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 2HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 4HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 5ARUP Laboratories Partners With Pathology Service Associates 2ARUP Laboratories Partners With Pathology Service Associates 3Medarex to Present at the Jefferies Second Annual Healthcare Conference 2
HSPBP1 Antibody...
golgi reassembly stacking protein 2, 55kDa...
...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products: